Soini Y, Salo T, Oikarinen A, Autio-Harmainen H
Department of Pathology, University of Oulu, Finland.
Lab Invest. 1993 Sep;69(3):305-11.
In previous studies, it has been shown that the stromal cells of epithelial tumors are capable of synthesizing 72 and 92 kilodalton (kd) type IV collagenase mRNA. The mRNA synthesis of these collagenases in mesenchymal tumors has not been extensively studied, however. This study was undertaken to explore the synthesis of 72 and 92 kd type IV collagenase mRNAs in malignant and benign fibrous histiocytomas and its correlation with the known biologic behavior of these tumors.
The synthesis of 72 kd and 92 kd type IV collagenase mRNA was studied in 10 malignant fibrous histiocytomas (MFHs) and 7 dermatofibromas using in situ hybridization methods. The tumors were also studied with a commercial monoclonal antibody to the 72 kd type IV collagenase. Additionally, three dermatofibromas were studied with an antibody to the 92 kd type IV collagenase. The media of three cell lines (MFH, dermatofibroma and skin fibroblast cell line) were also analyzed by zymography assay.
The results revealed mRNA for the 72 kd and 92 kd collagenases in tumor cells of both MFHs and dermatofibromas. Also intracytoplasmic immunoreactivity for the 72 kd type IV collagenase could be seen in all the tumors. In the zymography assay, 72 kd type IV collagenase activity was detected in the culture media of all the cell lines tested, but activity for the 92 kd enzyme was only seen in the MFH. However, immunoreactivity for the antibody to the 92 kd type IV collagenase was also seen in dermatofibromas.
The findings indicate that MFHs and dermatofibromas produce type IV collagenases. The synthesis of the mRNAs for both 72 kd and 92 kd type IV collagenase was quantitatively similar in MFHs and dermatofibromas indicating that there is no correlation between the biologic behavior of the tumors and the synthesis of these substances. Therefore, additional factors other than synthesis of type IV collagenases by tumor cells, must be involved in the process of spread and invasion of tumor cells into the neighbouring tissues.
在以往的研究中,已经表明上皮肿瘤的基质细胞能够合成72千道尔顿(kd)和92千道尔顿的IV型胶原酶信使核糖核酸(mRNA)。然而,间充质肿瘤中这些胶原酶的mRNA合成尚未得到广泛研究。本研究旨在探讨恶性和良性纤维组织细胞瘤中72kd和92kd IV型胶原酶mRNA的合成及其与这些肿瘤已知生物学行为的相关性。
采用原位杂交方法研究了10例恶性纤维组织细胞瘤(MFH)和7例皮肤纤维瘤中72kd和92kd IV型胶原酶mRNA的合成。还用针对72kd IV型胶原酶的商业单克隆抗体对肿瘤进行了研究。此外,用针对92kd IV型胶原酶的抗体研究了3例皮肤纤维瘤。还用酶谱分析法分析了三种细胞系(MFH、皮肤纤维瘤和皮肤成纤维细胞系)的培养基。
结果显示MFH和皮肤纤维瘤的肿瘤细胞中均有72kd和92kd胶原酶的mRNA。在所有肿瘤中也可见到72kd IV型胶原酶的胞浆内免疫反应性。在酶谱分析中,在所有测试的细胞系培养基中均检测到72kd IV型胶原酶活性,但仅在MFH中见到92kd酶的活性。然而,在皮肤纤维瘤中也可见到针对92kd IV型胶原酶抗体的免疫反应性。
研究结果表明MFH和皮肤纤维瘤产生IV型胶原酶。72kd和92kd IV型胶原酶mRNA的合成在MFH和皮肤纤维瘤中在数量上相似,表明肿瘤的生物学行为与这些物质的合成之间没有相关性。因此,肿瘤细胞向邻近组织扩散和侵袭的过程中,除了肿瘤细胞合成IV型胶原酶外,还必须涉及其他因素。